메뉴 건너뛰기




Volumn 78, Issue SUPPL. 119, 2010, Pages

Non-immune interventions to protect kidney allografts in the long term

Author keywords

chronic graft failure; hyperlipidemia; hypertension; kidney transplant; proteinuria

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO;

EID: 78649666348     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2010.427     Document Type: Conference Paper
Times cited : (19)

References (47)
  • 1
    • 43549091657 scopus 로고    scopus 로고
    • Thirty year trend in kidney transplants: UCLA and UNOS Renal Transplant Registry
    • Kaneku HK, Terasaki PI. Thirty year trend in kidney transplants: UCLA and UNOS Renal Transplant Registry. Clin Transpl 2006: 1-27.
    • (2006) Clin Transpl , pp. 1-27
    • Kaneku, H.K.1    Terasaki, P.I.2
  • 2
    • 0031778798 scopus 로고    scopus 로고
    • Protecting single-kidney allografts from long-term functional deterioration
    • Remuzzi G, Perico N. Protecting single-kidney allografts from long-term functional deterioration. J Am Soc Nephrol 1998; 9: 1321-1332.
    • (1998) J Am Soc Nephrol , vol.9 , pp. 1321-1332
    • Remuzzi, G.1    Perico, N.2
  • 3
    • 0001363498 scopus 로고
    • Nephron adaptation to renal injury or ablation
    • Brenner BM. Nephron adaptation to renal injury or ablation. Am J Physiol 1985; 249: F324-F337.
    • (1985) Am J Physiol , vol.249
    • Brenner, B.M.1
  • 4
    • 0031046924 scopus 로고    scopus 로고
    • Nephron mass modulates the hemodynamic, cellular, and molecular response of the rat renal allograft
    • Azuma H, Nadeau K, Mackenzie HS et al. Nephron mass modulates the hemodynamic, cellular, and molecular response of the rat renal allograft. Transplantation 1997; 63: 519-528.
    • (1997) Transplantation , vol.63 , pp. 519-528
    • Azuma, H.1    Nadeau, K.2    MacKenzie, H.S.3
  • 6
    • 34548859562 scopus 로고    scopus 로고
    • Sirolimus: Defining nephrotoxicity in the renal transplant recipient
    • Tomlanovich SJ, Vincenti F. Sirolimus: defining nephrotoxicity in the renal transplant recipient. Clin J Am Soc Nephrol 2007; 2: 198-199.
    • (2007) Clin J Am Soc Nephrol , vol.2 , pp. 198-199
    • Tomlanovich, S.J.1    Vincenti, F.2
  • 7
    • 32444451549 scopus 로고    scopus 로고
    • Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes
    • Remuzzi G, Benigni A, Remuzzi A. Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. J Clin Invest 2006; 116: 288-296.
    • (2006) J Clin Invest , vol.116 , pp. 288-296
    • Remuzzi, G.1    Benigni, A.2    Remuzzi, A.3
  • 9
    • 0033780696 scopus 로고    scopus 로고
    • Recommendations for the outpatient surveillance of renal transplant recipients
    • American Society of Transplantation
    • Kasiske BL, Vazquez MA, Harmon WE et al. Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol 2000; 15: S1-S86.
    • (2000) J Am Soc Nephrol , vol.15
    • Kasiske, B.L.1    Vazquez, M.A.2    Harmon, W.E.3
  • 10
  • 11
    • 0026878341 scopus 로고
    • Cyclosporine and posttransplant hypertension
    • Curtis JJ. Cyclosporine and posttransplant hypertension. J Am Soc Nephrol 1992; 2: S243-S245.
    • (1992) J Am Soc Nephrol , vol.2
    • Curtis, J.J.1
  • 12
    • 0034594631 scopus 로고    scopus 로고
    • Arterial hypertension and renal allograft survival
    • Mange KC, Cizman B, Joffe M et al. Arterial hypertension and renal allograft survival. JAMA 2000; 283: 633-638.
    • (2000) JAMA , vol.283 , pp. 633-638
    • Mange, K.C.1    Cizman, B.2    Joffe, M.3
  • 13
    • 0033852481 scopus 로고    scopus 로고
    • Preserving renal function in adults with hypertension and diabetes: A consensus approach
    • National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group
    • Bakris GL, Williams M, Dworkin L et al. Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis 2000; 36: 646-661.
    • (2000) Am J Kidney Dis , vol.36 , pp. 646-661
    • Bakris, G.L.1    Williams, M.2    Dworkin, L.3
  • 14
    • 19944432352 scopus 로고    scopus 로고
    • Effect of lifestyle modifications on blood pressure by race, sex, hypertension status, and age
    • Svetkey LP, Erlinger TP, Vollmer WM et al. Effect of lifestyle modifications on blood pressure by race, sex, hypertension status, and age. J Hum Hypertens 2005; 19: 21-31.
    • (2005) J Hum Hypertens , vol.19 , pp. 21-31
    • Svetkey, L.P.1    Erlinger, T.P.2    Vollmer, W.M.3
  • 15
    • 9044253049 scopus 로고
    • Nifedipine improves immediate, and 6- and 12-month graft function in cyclosporin A (CyA) treated renal allograft recipients
    • Harper SJ, Moorhouse J, Veitch PS et al. Nifedipine improves immediate, and 6- and 12-month graft function in cyclosporin A (CyA) treated renal allograft recipients. Transpl Int 1992; 5(Suppl 1): S69-S72.
    • (1992) Transpl Int , vol.5 , Issue.SUPPL. 1
    • Harper, S.J.1    Moorhouse, J.2    Veitch, P.S.3
  • 16
    • 37349034394 scopus 로고    scopus 로고
    • Reduced exposure to calcineurin inhibitors in renal transplantation
    • Ekberg H, Tedesco-Silva H, Demirbas A et al. Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med 2007; 357: 2562-2575.
    • (2007) N Engl J Med , vol.357 , pp. 2562-2575
    • Ekberg, H.1    Tedesco-Silva, H.2    Demirbas, A.3
  • 17
    • 0037145856 scopus 로고    scopus 로고
    • Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: Results from the AASK trial
    • Wright Jr JT, Bakris G, Greene T et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA 2002; 288: 2421-2431.
    • (2002) JAMA , vol.288 , pp. 2421-2431
    • Wright Jr., J.T.1    Bakris, G.2    Greene, T.3
  • 18
    • 0035816018 scopus 로고    scopus 로고
    • Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: A randomized controlled trial
    • Agodoa LY, Appel L, Bakris GL et al. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. JAMA 2001; 285: 2719-2728.
    • (2001) JAMA , vol.285 , pp. 2719-2728
    • Agodoa, L.Y.1    Appel, L.2    Bakris, G.L.3
  • 19
    • 48549095799 scopus 로고    scopus 로고
    • Angiotensin receptor blockers: Current status and future prospects
    • Ram CV. Angiotensin receptor blockers: current status and future prospects. Am J Med 2008; 121: 656-663.
    • (2008) Am J Med , vol.121 , pp. 656-663
    • Ram, C.V.1
  • 20
    • 19644400972 scopus 로고    scopus 로고
    • Angiotensin-converting-enzyme inhibition in stable coronary artery disease
    • Braunwald E, Domanski MJ, Fowler SE et al. Angiotensin-converting-enzyme inhibition in stable coronary artery disease. N Engl J Med 2004; 351: 2058-2068.
    • (2004) N Engl J Med , vol.351 , pp. 2058-2068
    • Braunwald, E.1    Domanski, M.J.2    Fowler, S.E.3
  • 21
    • 0030604561 scopus 로고    scopus 로고
    • Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy
    • The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia)
    • Ruggenenti P, Perna A, Mosconi L et al. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia). Lancet 1997; 349: 1857-1863.
    • (1997) Lancet , vol.349 , pp. 1857-1863
    • Ruggenenti, P.1    Perna, A.2    Mosconi, L.3
  • 22
    • 36849003353 scopus 로고    scopus 로고
    • Is RAS blockade routinely indicated in hypertensive kidney transplant patients?
    • Salzberg DJ. Is RAS blockade routinely indicated in hypertensive kidney transplant patients? Curr Hypertens Rep 2007; 9: 422-429.
    • (2007) Curr Hypertens Rep , vol.9 , pp. 422-429
    • Salzberg, D.J.1
  • 23
    • 33748778507 scopus 로고    scopus 로고
    • Cardiovascular complications after renal transplantation and their prevention
    • Ojo AO. Cardiovascular complications after renal transplantation and their prevention. Transplantation 2006; 82: 603-611.
    • (2006) Transplantation , vol.82 , pp. 603-611
    • Ojo, A.O.1
  • 24
    • 0024210425 scopus 로고
    • Proteinuria in renal transplant recipients: Incidence, cause, prognostic importance
    • Bear RA, Aprile M, Sweet J et al. Proteinuria in renal transplant recipients: incidence, cause, prognostic importance. Transplant Proc 1988; 20: 1235-1236.
    • (1988) Transplant Proc , vol.20 , pp. 1235-1236
    • Bear, R.A.1    Aprile, M.2    Sweet, J.3
  • 26
    • 30344442801 scopus 로고    scopus 로고
    • Angiotensin II: A key factor in the inflammatory and fibrotic response in kidney diseases
    • Ruiz-Ortega M, Ruperez M, Esteban V et al. Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases. Nephrol Dial Transplant 2006; 21: 16-20.
    • (2006) Nephrol Dial Transplant , vol.21 , pp. 16-20
    • Ruiz-Ortega, M.1    Ruperez, M.2    Esteban, V.3
  • 27
    • 1242351306 scopus 로고    scopus 로고
    • The renin-angiotensin-aldosterone system and the kidney: Effects on kidney disease
    • Brewster UC, Perazella MA. The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease. Am J Med 2004; 116: 263-272.
    • (2004) Am J Med , vol.116 , pp. 263-272
    • Brewster, U.C.1    Perazella, M.A.2
  • 28
    • 0344514607 scopus 로고    scopus 로고
    • ACE inhibition limits chronic injury of kidney transplant even with treatment started when lesions are established
    • Noris M, Mister M, Pezzotta A et al. ACE inhibition limits chronic injury of kidney transplant even with treatment started when lesions are established. Kidney Int 2003; 64: 2253-2261.
    • (2003) Kidney Int , vol.64 , pp. 2253-2261
    • Noris, M.1    Mister, M.2    Pezzotta, A.3
  • 29
    • 33645451066 scopus 로고    scopus 로고
    • Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation
    • Heinze G, Mitterbauer C, Regele H et al. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation. J Am Soc Nephrol 2006; 17: 889-899.
    • (2006) J Am Soc Nephrol , vol.17 , pp. 889-899
    • Heinze, G.1    Mitterbauer, C.2    Regele, H.3
  • 30
    • 34548301629 scopus 로고    scopus 로고
    • Renin angiotensin system blockade in kidney transplantation: A systematic review of the evidence
    • Hiremath S, Fergusson D, Doucette S et al. Renin angiotensin system blockade in kidney transplantation: a systematic review of the evidence. Am J Transplant 2007; 7: 2350-2360.
    • (2007) Am J Transplant , vol.7 , pp. 2350-2360
    • Hiremath, S.1    Fergusson, D.2    Doucette, S.3
  • 31
    • 13444267698 scopus 로고    scopus 로고
    • Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection
    • Dragun D, Muller DN, Brasen JH et al. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med 2005; 352: 558-569.
    • (2005) N Engl J Med , vol.352 , pp. 558-569
    • Dragun, D.1    Muller, D.N.2    Brasen, J.H.3
  • 32
    • 44449094269 scopus 로고    scopus 로고
    • The Canadian ACE-inhibitor trial to improve renal outcomes and patient survival in kidney transplantation- study design
    • Knoll GA, Cantarovitch M, Cole E et al. The Canadian ACE-inhibitor trial to improve renal outcomes and patient survival in kidney transplantation- study design. Nephrol Dial Transplant 2008; 23: 354-358.
    • (2008) Nephrol Dial Transplant , vol.23 , pp. 354-358
    • Knoll, G.A.1    Cantarovitch, M.2    Cole, E.3
  • 33
    • 53549111038 scopus 로고    scopus 로고
    • Dyslipidemia in chronic kidney disease: An approach to pathogenesis and treatment
    • Tsimihodimos V, Dounousi E, Siamopoulos KC. Dyslipidemia in chronic kidney disease: an approach to pathogenesis and treatment. Am J Nephrol 2008; 28: 958-973.
    • (2008) Am J Nephrol , vol.28 , pp. 958-973
    • Tsimihodimos, V.1    Dounousi, E.2    Siamopoulos, K.C.3
  • 34
    • 3242666237 scopus 로고    scopus 로고
    • The effects of hyperlipidaemia on graft and patient outcome in renal transplantation
    • Del Castillo D, Cruzado JM, Manel Diaz J et al. The effects of hyperlipidaemia on graft and patient outcome in renal transplantation. Nephrol Dial Transplant 2004; 19(Suppl 3): iii67-iii71.
    • (2004) Nephrol Dial Transplant , vol.19 , Issue.SUPPL. 3
    • Del Castillo, D.1    Cruzado, J.M.2    Manel Diaz, J.3
  • 35
    • 55349133352 scopus 로고    scopus 로고
    • Present and future drug treatments for chronic kidney diseases: Evolving targets in renoprotection
    • Perico N, Benigni A, Remuzzi G. Present and future drug treatments for chronic kidney diseases: evolving targets in renoprotection. Nat Rev Drug Discov 2008; 7: 936-953.
    • (2008) Nat Rev Drug Discov , vol.7 , pp. 936-953
    • Perico, N.1    Benigni, A.2    Remuzzi, G.3
  • 36
    • 10744229858 scopus 로고    scopus 로고
    • Effect of fluvastatin on cardiac outcomes in renal transplant recipients: A multicentre, randomised, placebo-controlled trial
    • Holdaas H, Fellstrom B, Jardine AG et al. Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial. Lancet 2003; 361: 2024-2031.
    • (2003) Lancet , vol.361 , pp. 2024-2031
    • Holdaas, H.1    Fellstrom, B.2    Jardine, A.G.3
  • 37
    • 4644278069 scopus 로고    scopus 로고
    • Effect of fluvastatin on renal end points in the Assessment of Lescol in Renal Transplant (ALERT) trial
    • Fellstrom B, Holdaas H, Jardine AG et al. Effect of fluvastatin on renal end points in the Assessment of Lescol in Renal Transplant (ALERT) trial. Kidney Int 2004; 66: 1549-1555.
    • (2004) Kidney Int , vol.66 , pp. 1549-1555
    • Fellstrom, B.1    Holdaas, H.2    Jardine, A.G.3
  • 38
    • 49849102254 scopus 로고    scopus 로고
    • Fluvastatin in the prevention of renal transplant vasculopathy: Results of a prospective, randomized, double-blind, placebo-controlled trial
    • Seron D, Oppenheimer F, Pallardo LM et al. Fluvastatin in the prevention of renal transplant vasculopathy: results of a prospective, randomized, double-blind, placebo-controlled trial. Transplantation 2008; 86: 82-87.
    • (2008) Transplantation , vol.86 , pp. 82-87
    • Seron, D.1    Oppenheimer, F.2    Pallardo, L.M.3
  • 39
    • 11144271126 scopus 로고    scopus 로고
    • Identification of medication-adherence barriers and strategies to increase adherence in recipients of renal transplants
    • Chisholm MA. Identification of medication-adherence barriers and strategies to increase adherence in recipients of renal transplants. Manag Care Interface 2004; 17: 44-48.
    • (2004) Manag Care Interface , vol.17 , pp. 44-48
    • Chisholm, M.A.1
  • 40
    • 4344626592 scopus 로고    scopus 로고
    • Prospective study on late consequences of subclinical non-compliance with immunosuppressive therapy in renal transplant patients
    • Vlaminck H, Maes B, Evers G et al. Prospective study on late consequences of subclinical non-compliance with immunosuppressive therapy in renal transplant patients. Am J Transplant 2004; 4: 1509-1513.
    • (2004) Am J Transplant , vol.4 , pp. 1509-1513
    • Vlaminck, H.1    Maes, B.2    Evers, G.3
  • 41
    • 58149120959 scopus 로고    scopus 로고
    • Compliance of kidney transplant patients to the recommended lifestyle behaviours: Single centre experience
    • Gheith OA, El-Saadany SA, Abuo Donia SA et al. Compliance of kidney transplant patients to the recommended lifestyle behaviours: single centre experience. Int J Nurs Pract 2008; 14: 398-407.
    • (2008) Int J Nurs Pract , vol.14 , pp. 398-407
    • Gheith, O.A.1    El-Saadany, S.A.2    Abuo Donia, S.A.3
  • 42
    • 0842281681 scopus 로고    scopus 로고
    • Cigarette smoking in renal transplant recipients
    • Yavuz A, Tuncer M, Gurkan A et al. Cigarette smoking in renal transplant recipients. Transplant Proc 2004; 36: 108-110.
    • (2004) Transplant Proc , vol.36 , pp. 108-110
    • Yavuz, A.1    Tuncer, M.2    Gurkan, A.3
  • 43
    • 34047266333 scopus 로고    scopus 로고
    • Cigarette smoking as a risk factor for atherosclerosis and renal disease: Novel pathogenic insights
    • Mercado C, Jaimes EA. Cigarette smoking as a risk factor for atherosclerosis and renal disease: novel pathogenic insights. Curr Hypertens Rep 2007; 9: 66-72.
    • (2007) Curr Hypertens Rep , vol.9 , pp. 66-72
    • Mercado, C.1    Jaimes, E.A.2
  • 44
    • 4444334341 scopus 로고    scopus 로고
    • Nutrition for the post-renal transplant recipients
    • Martins C, Pecoits-Filho R, Riella MC. Nutrition for the post-renal transplant recipients. Transplant Proc 2004; 36: 1650-1654.
    • (2004) Transplant Proc , vol.36 , pp. 1650-1654
    • Martins, C.1    Pecoits-Filho, R.2    Riella, M.C.3
  • 45
    • 48149112155 scopus 로고    scopus 로고
    • Sirolimus is associated with new-onset diabetes in kidney transplant recipients
    • Johnston O, Rose CL, Webster AC et al. Sirolimus is associated with new-onset diabetes in kidney transplant recipients. J Am Soc Nephrol 2008; 19: 1411-1418.
    • (2008) J Am Soc Nephrol , vol.19 , pp. 1411-1418
    • Johnston, O.1    Rose, C.L.2    Webster, A.C.3
  • 46
    • 33645083493 scopus 로고    scopus 로고
    • Posttransplant diabetes mellitus: Impact of good blood glucose regulation on renal transplant recipient outcome
    • Sezer S, Akgul A, Altinoglu A et al. Posttransplant diabetes mellitus: impact of good blood glucose regulation on renal transplant recipient outcome. Transplant Proc 2006; 38: 533-536.
    • (2006) Transplant Proc , vol.38 , pp. 533-536
    • Sezer, S.1    Akgul, A.2    Altinoglu, A.3
  • 47
    • 48049100806 scopus 로고    scopus 로고
    • Role of remission clinics in the longitudinal treatment of CKD
    • Ruggenenti P, Perticucci E, Cravedi P et al. Role of remission clinics in the longitudinal treatment of CKD. J Am Soc Nephrol 2008; 19: 1213-1224.
    • (2008) J Am Soc Nephrol , vol.19 , pp. 1213-1224
    • Ruggenenti, P.1    Perticucci, E.2    Cravedi, P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.